Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | CD69 | Q07108 | 2/20 | 0.42 |
| ▸ | LGALS8 | O00214 | 3/20 | 0.41 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.40 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.40 |
| ▸ | PYGB | P11216 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24454404 | 0.87 | MAPK1 (0.39) | MAPK1ALDH1A1THRBCD69 | |
| SCHEMBL11425414 | 0.87 | MAPK1 (0.66) | MAPK1ALDH1A1THRBCD69LGALS8 | |
| SCHEMBL22560327 | 0.87 | MAPK1 (0.52) | MAPK1ALDH1A1THRBCD69LGALS8 | |
| SCHEMBL7888483 | 0.87 | MAPK1 (0.66) | MAPK1ALDH1A1THRBCD69LGALS8 | |
| SCHEMBL7888480 | 0.87 | MAPK1 (0.66) | MAPK1ALDH1A1THRBCD69LGALS8 | |
| SCHEMBL8000037 | 0.87 | MAPK1 (0.66) | MAPK1ALDH1A1THRBCD69LGALS8 | |
| SCHEMBL8000040 | 0.87 | MAPK1 (0.66) | MAPK1ALDH1A1THRBCD69LGALS8 | |
| SCHEMBL23603141 | 0.87 | MAPK1 (0.52) | MAPK1ALDH1A1THRBCD69LGALS8 | |
| SCHEMBL21077729 | 0.87 | MAPK1 (0.52) | MAPK1ALDH1A1THRBCD69LGALS8 | |
| SCHEMBL13864090 | 0.87 | MAPK1 (0.52) | MAPK1ALDH1A1THRBCD69LGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220162252-A1 | SYNTHESIS OF 6-AZIDO-6-DEOXY-2-N-ACETYL-HEXOSAMINE-NUCLEOSIDE DIPHOSPHATE | SYNAFFIX B.V. (NL) | 2022-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220162252-A1 | SYNTHESIS OF 6-AZIDO-6-DEOXY-2-N-ACETYL-HEXOSAMINE-NUCLEOSIDE DIPHOSPHATE | FUT6, NANS, B3GNT2 | MAPK1 3963/4885ALDH1A1 801/4885THRB 3854/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.